2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details


臨床試験数 : 645 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05176093
(ClinicalTrials.gov)
November 14, 20215/11/2021A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral SclerosisA 6-Month Extension Study Following Protocol VMALS-002-2 (A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis)Amyotrophic Lateral SclerosisBiological: Engensis;Other: PlaceboHelixmith Co., Ltd.NULLCompleted18 Years80 YearsAll8Phase 2United States;Korea, Republic of
2NCT04632225
(ClinicalTrials.gov)
February 9, 202129/10/2020Safety of Engensis in Participants With Amyotrophic Lateral SclerosisA Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisBiological: Engensis;Other: PlaceboHelixmith Co., Ltd.NULLCompleted18 Years80 YearsAll18Phase 2United States;Korea, Republic of